These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 26527801)

  • 1. Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance.
    Palmer DC; Guittard GC; Franco Z; Crompton JG; Eil RL; Patel SJ; Ji Y; Van Panhuys N; Klebanoff CA; Sukumar M; Clever D; Chichura A; Roychoudhuri R; Varma R; Wang E; Gattinoni L; Marincola FM; Balagopalan L; Samelson LE; Restifo NP
    J Exp Med; 2015 Nov; 212(12):2095-113. PubMed ID: 26527801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cish SH2 domain is essential for PLC-γ1 regulation in TCR stimulated CD8
    Guittard G; Dios-Esponera A; Palmer DC; Akpan I; Barr VA; Manna A; Restifo NP; Samelson LE
    Sci Rep; 2018 Mar; 8(1):5336. PubMed ID: 29593227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential.
    Davey GM; Starr R; Cornish AL; Burghardt JT; Alexander WS; Carbone FR; Surh CD; Heath WR
    J Exp Med; 2005 Oct; 202(8):1099-108. PubMed ID: 16216888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive T Cell Therapy with IL-12-Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity.
    Tucker CG; Mitchell JS; Martinov T; Burbach BJ; Beura LK; Wilson JC; Dwyer AJ; Singh LM; Mescher MF; Fife BT
    J Immunol; 2020 Sep; 205(5):1449-1460. PubMed ID: 32737148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control.
    Kesarwani P; Chakraborty P; Gudi R; Chatterjee S; Scurti G; Toth K; Simms P; Husain M; Armeson K; Husain S; Garrett-Mayer E; Vasu C; Nishimura MI; Mehrotra S
    Oncotarget; 2016 Oct; 7(43):69371-69383. PubMed ID: 27750220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
    Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
    Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cytokine-driven functional differentiation of CD8 T cells by suppressor of cytokine signaling 1 controls autoimmunity and preserves their proliferative capacity toward foreign antigens.
    Ramanathan S; Dubois S; Gagnon J; Leblanc C; Mariathasan S; Ferbeyre G; Rottapel R; Ohashi PS; Ilangumaran S
    J Immunol; 2010 Jul; 185(1):357-66. PubMed ID: 20519645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells: CiShh..
    Bird L
    Nat Rev Immunol; 2015 Dec; 15(12):728-9. PubMed ID: 26603898
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27.
    Brender C; Tannahill GM; Jenkins BJ; Fletcher J; Columbus R; Saris CJ; Ernst M; Nicola NA; Hilton DJ; Alexander WS; Starr R
    Blood; 2007 Oct; 110(7):2528-36. PubMed ID: 17609432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size.
    Liu SD; Tomassian T; Bruhn KW; Miller JF; Poirier F; Miceli MC
    J Immunol; 2009 May; 182(9):5283-95. PubMed ID: 19380775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.
    Chandran SS; Paria BC; Srivastava AK; Rothermel LD; Stephens DJ; Kammula US
    Cancer Res; 2015 Aug; 75(16):3216-26. PubMed ID: 26100671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of IL-21 signaling by suppressor of cytokine signaling-1 (SOCS1) in CD8(+) T lymphocytes.
    Gagnon J; Ramanathan S; Leblanc C; Ilangumaran S
    Cell Signal; 2007 Apr; 19(4):806-16. PubMed ID: 17126530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ.
    Moran AE; Polesso F; Weinberg AD
    J Immunol; 2016 Sep; 197(6):2509-21. PubMed ID: 27503208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avidity characterization of genetically engineered T-cells with novel and established approaches.
    Hillerdal V; Boura VF; Björkelund H; Andersson K; Essand M
    BMC Immunol; 2016 Jul; 17(1):23. PubMed ID: 27411667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of T-cell Receptor-Modified T Cells for Cancer Therapy.
    Drakes DJ; Rafiq S; Purdon TJ; Lopez AV; Chandran SS; Klebanoff CA; Brentjens RJ
    Cancer Immunol Res; 2020 Jun; 8(6):743-755. PubMed ID: 32209638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation.
    Yang M; Chen T; Li X; Yu Z; Tang S; Wang C; Gu Y; Liu Y; Xu S; Li W; Zhang X; Wang J; Cao X
    Nat Immunol; 2015 Dec; 16(12):1253-62. PubMed ID: 26390156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
    Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
    Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-avidity T cells are preferentially tolerized in the tumor microenvironment.
    Zhu Z; Singh V; Watkins SK; Bronte V; Shoe JL; Feigenbaum L; Hurwitz AA
    Cancer Res; 2013 Jan; 73(2):595-604. PubMed ID: 23204239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Essential Role of the Avidity of T-Cell Receptor in Differentiation of Self-Antigen-reactive CD8+ T Cells.
    Kondo K; Fujiki F; Nakajima H; Yatsukawa E; Morimoto S; Tatsumi N; Nishida S; Nakata J; Oka Y; Tsuboi A; Hosen N; Oji Y; Sugiyama H
    J Immunother; 2016 Apr; 39(3):127-39. PubMed ID: 26938946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.